DINESH

Fortis Healthcare

Industry: Healthcare
Latest CMP 929
Today's Change ▲ 2.52%
52-Week High / Low 1,097 | 788
Price Date: 14-Aug-2026
Recommendation Buy
Target Price 1,240
Expected Upside 15.5%
Forecast Horizon 2 Years
Historical CAGR 13.1%
1,000 Invested 09-May-2007
Today's Value 10,791
Investment Period 19 Years

Stock Snapshot

Post Results Return
-2.5%
Neutral Market Reaction
1-Year Target Price
1,132
2-Year Target Price
1,240
52-Week High / Low
1,097 / 788
20-Day Return
-2.2%
Market Cap (Cr.)
70,136
Current PE
67.6
P/BV Ratio
7.1
Dividend Yield
0.2%
Industry PE
57.2

Price Performance

Basis of our Recommendation

Fortis Healthcare's recent management commentary highlights a disciplined brownfield expansion strategy aimed at adding 1,800 beds by FY30, which is expected to drive long-term revenue growth. The company is focused on improving operational metrics, particularly in its diagnostics segment, despite facing short-term margin pressures due to ESOP costs and regulatory challenges in oncology pricing. Vista's financial outlook anticipates a moderate revenue growth rate of over 15% for FY27, supported by the company's strategic initiatives and a strong balance sheet. The expected EBITDA margin improvement to 25% by FY28 aligns with management's guidance, although ongoing execution risks and competitive dynamics in key markets remain watchpoints. The healthcare sector's stable pricing power and growth in corporate healthcare provide a favorable backdrop, despite macroeconomic inflationary pressures. Over the next 12-24 months, key opportunities include the successful integration of new facilities and advancements in digital healthcare, while headwinds may arise from regulatory constraints and the need for skilled healthcare professionals

👍 Why We Like This Stock

  • Disciplined brownfield expansion strategy targeting 1,800 new beds by FY30
  • Management's commitment to achieving a 25% EBITDA margin by FY28 supports long-term profitability
  • Strong balance sheet and operational improvements in diagnostics enhance growth potential

Things To Watch Out For

  • Short-term margin pressures from ESOP costs and regulatory pricing challenges in oncology
  • Execution risks associated with integrating new facilities and maintaining service quality
  • Potential impact of skilled healthcare professional shortages on operational efficiency

Key Parameters

Balance Sheet Strength
Strong and Investable
Market Share
Stable
Industry Outlook
Stable
Analyst View
Strong Buy
Dividend History
Regular
FII Holdings
Reducing

Financial Snapshot

Actuals Forecast
FY24 FY25 FY26 FY27 FY28
Revenue (Cr.) 6,893 7,783 9,128 9,635 11,151
Profit Before Tax (Cr.) 838 1,093 1,388 1,504 1,922
PBT Margin 12.2% 14.0% 1520.6% 15.6% 17.2%
Net Profit (Cr.) 676 893 1,081 1,173 1,469
Earnings Per Share 8.3 11.4 14.0 15.2 19.5

Analyst Recommendations

Broker Recommendation Target Price Date
Choice Equity ▲ Buy 1,140 26-May-2026
Citigroup ▲ Buy 1,180 10-Aug-2026
Geojit Financials ▲ Buy 1,150 16-Jun-2026
Goldman Sachs ► Neutral 975 10-Aug-2026
HSBC ▲ Buy 1,200 07-Aug-2026
ICICI Securities ▲ Overweight 1,075 09-Aug-2026
JPMorgan ▲ Overweight 1,180 10-Aug-2026
Jeffries ▲ Overweight 1,125 10-Aug-2026
Motilal Oswal ▲ Buy 1,130 10-Aug-2026
Nomura ► Neutral 990 07-Aug-2026
Nuvama ▲ Buy 1,145 25-May-2026
Prabhudas Liladhar ▲ Buy 1,120 10-Aug-2026
Consensus Recommendation ▲ Strong Buy
Consensus Target 1,116
Coverage 12 Analysts
Analysts' Viewpoint
Fortis Healthcare's growth strategy centers on expanding capacity through brownfield projects and enhancing operational efficiencies, with a target of 25% EBITDA margins by FY28. Analysts highlight the potential for long-term revenue growth from the planned addition of 1,800 beds and strategic priorities like scaling the FMRI hospital and integrating oncology services. However, short-term profitability is constrained by ESOP-related expenses and regulatory pricing pressures in oncology. Future catalysts include the commissioning of new beds and stabilization of recent acquisitions.

Company Overview

Show Company Profile

Fortis Healthcare Limited operates as a healthcare delivery service provider in India. The company offers services in the areas of cardiac science, critical care, vascular surgery, dental science, dermatology, diabetology/endocrinology, emergency and trauma, geriatric medicine, liver transplant and hepatobiliary sciences, pain and palliative medicine, ENT, foetal medicine, gastroenterology and hepatology science, general surgery, and haematology areas. It also provides services in the areas of infertility medicine, internal medicine, mental health and behavioral science, nephrology, neuro surgery, neurointerventional radiology, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy and rehabilitation, plastic and reconstructive surgery, pulmonology, radiology, organ transplant, rheumatology, thoracic surgery, transfusion medicine, urology, medical generics, endocrine surgery, and other support specialties, as well as treat infectious diseases. The company's healthcare verticals comprise hospitals, diagnostics, tertiary and quaternary care, and day care specialty facilities. Fortis Healthcare Limited was incorporated in 1996 and is based in Gurugram, India.